Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Wang Y, Zhang D, Du G, Du R, et al. Lancet 2020;395:1569-1578.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Y, Zhang D, Du G, Du R, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2020;395:1569-1578.
PMID: 32423584